Source: BioPortfolio

SafeTec: SafeTEC Drug Safety Technology Consortium Organizes Validation Project of Cyclicas Ligand Express Platform Recruiting More Participants

In a blinded study members of the SafeTEC consortium managed by One Million Solutions in Health will evaluate the ability of Cyclicas technologies to predict drugprotein interactions and verify the Cyclica in silico results with industryconducted in vitro ...

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Jim Frohlich's photo - President & CEO of SafeTec

President & CEO

Jim Frohlich

CEO Approval Rating

71/100

Read more